Cargando…

miR-34a Regulates Multidrug Resistance via Positively Modulating OAZ2 Signaling in Colon Cancer Cells

Although aberrant expression of miR-34a, an essential tumor suppressor miRNA, has been frequently observed in colon cancer (CCa), whether miR-34a can regulate CCa progression by modulating other facets of this malignancy (such as multidrug resistance, MDR) remains unknown. Here, we report for the fi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yong, Gong, Ping, Hou, Ji-xue, Huang, Wei, Ma, Xiao-ping, Wang, Yu-li, Li, Jing, Cui, Xiao-bin, Li, Na
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098920/ https://www.ncbi.nlm.nih.gov/pubmed/30175154 http://dx.doi.org/10.1155/2018/7498514

Ejemplares similares

OAZ-t/OAZ3 Is Essential for Rigid Connection of Sperm Tails to Heads in Mouse
por: Tokuhiro, Keizo, et al.
Publicado: (2009)

miR-103/miR-195/miR-15b Regulate SALL4 and Inhibit Proliferation and Migration in Glioma
por: Chen, Li-Ping, et al.
Publicado: (2018)

Expression and diagnostic value of miR-34c and miR-141 in serum of patients with colon cancer
por: Wu, Huijing, et al.
Publicado: (2020)

MiR-34a regulates apoptosis in liver cells by targeting the KLF4 gene
por: Chen, Qiu, et al.
Publicado: (2014)

miR-34a induces spine damages via inhibiting synaptotagmin-1 in depression
por: Yi, Li-Tao, et al.
Publicado: (2020)

Values of miR-34a and miR-218 expression in the diagnosis of cervical cancer and the prediction of prognosis
por: Wang, Ping, et al.
Publicado: (2018)

Posttranscriptional deregulation of Src due to aberrant miR34a and miR203 contributes to gastric cancer development
por: Hao, Qiang, et al.
Publicado: (2013)

OAZ1 knockdown enhances viability and inhibits ER and LHR transcriptions of granulosa cells in geese
por: Kang, Bo, et al.
Publicado: (2017)

Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
por: Chim, Chor Sang, et al.
Publicado: (2011)

miR-34a expression in human breast cancer is associated with drug resistance
por: Li, Zhi-Hua, et al.
Publicado: (2017)

MiR-34a in Age and Tissue Related Radio-Sensitivity and Serum miR-34a as a Novel Indicator of Radiation Injury
por: Liu, Cong, et al.
Publicado: (2011)

miR-34 modulates wing polyphenism in planthopper
por: Ye, Xinhai, et al.
Publicado: (2019)

Quantitative Proteomic Analysis of Gene Regulation by miR-34a and miR-34c
por: Ebner, Olivia A., et al.
Publicado: (2014)

Circulatory miR-34a as an RNA-based, noninvasive biomarker for brain aging
por: Li, Xiaoli, et al.
Publicado: (2011)

miR-34 Modulates Innate Immunity and Ecdysone Signaling in Drosophila
por: Xiong, Xiao-Peng, et al.
Publicado: (2016)

Plasma microRNAs, miR-223, miR-21 and miR-218, as Novel Potential Biomarkers for Gastric Cancer Detection
por: Li, Bo-sheng, et al.
Publicado: (2012)

The Mechanism of miR-155/miR-15b Axis Contributed to Apoptosis of CD34+ Cells by Upregulation of PD-L1 in Myelodysplastic Syndromes
por: Cao, MeiWan, et al.
Publicado: (2023)

A Presenilin/Notch1 pathway regulated by miR-375, miR-30a, and miR-34a mediates glucotoxicity induced-pancreatic beta cell apoptosis
por: Li, Yating, et al.
Publicado: (2016)

MiR-34a regulates blood–tumor barrier function by targeting protein kinase Cε
por: Zhao, Wei, et al.
Publicado: (2015)

MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A
por: Li, Huiling, et al.
Publicado: (2016)

Baicalin-modified polyethylenimine for miR-34a efficient and safe delivery
por: Wang, Yingying, et al.
Publicado: (2023)

Role of Kallistatin Treatment in Aging and Cancer by Modulating miR-34a and miR-21 Expression
por: Chao, Julie, et al.
Publicado: (2017)

MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells
por: Zheng, Shun-Zhen, et al.
Publicado: (2019)

Small molecule targeting miR-34a for cancer therapy
por: Xiao, Zhangang, et al.
Publicado: (2015)

Dysregulation of the miR-34a-SIRT1 axis inhibits breast cancer stemness
por: Ma, Wei, et al.
Publicado: (2015)

MiR-34a and miR-34b/c have distinct effects on the suppression of lung adenocarcinomas
por: Kim, Jeong Seon, et al.
Publicado: (2019)

Analysis of the miR-34 family functions in breast cancer reveals annotation error of miR-34b
por: Engkvist, M. E., et al.
Publicado: (2017)

Expression and significance of miR-654-5p and miR-376b-3p in patients with colon cancer
por: Li, Ping, et al.
Publicado: (2020)

Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
por: Li, Heng, et al.
Publicado: (2014)

Conservation and diversification of the miR166 family in soybean and potential roles of newly identified miR166s
por: Li, Xuyan, et al.
Publicado: (2017)

LINC02418 promotes colon cancer progression by suppressing apoptosis via interaction with miR-34b-5p/BCL2 axis
por: Tian, Jun, et al.
Publicado: (2020)

miR-34: from bench to bedside
por: Agostini, Massimiliano, et al.
Publicado: (2014)

Aberration methylation of miR-34b was involved in regulating vascular calcification by targeting Notch1
por: Lin, Xiao, et al.
Publicado: (2019)

Persistent distention of colon damages interstitial cells of Cajal through Ca(2+)‐ERK‐AP‐1‐miR‐34c‐SCF deregulation
por: Yang, Shu, et al.
Publicado: (2017)

MALAT1 regulates miR-34a expression in melanoma cells
por: Li, Fei, et al.
Publicado: (2019)

lncRNA KCNQ1OT1 enhances the chemoresistance of oxaliplatin in colon cancer by targeting the miR-34a/ATG4B pathway
por: Li, Yongchao, et al.
Publicado: (2019)

Upregulation of MiR-1274a is Correlated with Survival Outcomes and Promotes Cell Proliferation, Migration, and Invasion of Colon Cancer
por: Ren, Bin, et al.
Publicado: (2020)

Erratum to: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
por: Li, Heng, et al.
Publicado: (2014)

Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy
por: Li, Heng, et al.
Publicado: (2022)

Targeting HDAC/OAZ1 axis with a novel inhibitor effectively reverses cisplatin resistance in non-small cell lung cancer
por: Sun, Yuhong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1et6vm463l35tj9piffj7epoee